Dermatan sulfate and heparan sulfate and keratan sulfate panel - DBS 94586-5
LOINC Code
LOINC code | 94586-5 | ||
---|---|---|---|
name | Dermatan sulfate and heparan sulfate and keratan sulfate panel - DBS | ||
description | This panel contains quantitative measurements of dermatan sulfate (DS), heparin sulfate (HS), and keratan sulfate (KS) in dried blood spots. Elevations of dermatan sulfate and/or heparan sulfate is associated with mucopolysaccharidoses types I, II, III, or VI. Elevations of keratan sulfate is associated with mucopolysaccharidoses type IV. Testing is performed to screen newborns for mucopolysaccharidosis (MPS) types I and II and to aid in the diagnosis and monitoring of patients with MPS types I, II, III, IV, and VI. | ||
status | ACTIVE | ||
Fully-Specified Name | |||
component | Dermatan sulfate & heparan sulfate & keratan sulfate panel | ||
property | - | ||
time | Pt = Point in time: To identify measures at a point in time. This is a synonym for “spot” or “random” as applied to urine measurements. | ||
system | Bld.dot = Blood filter paper | ||
scale | - | ||
method | |||
Additional Names | |||
short name | MPS panel DBS | ||
Basic Attributes | |||
class | PANEL.CHEM | ||
type | 1 Laboratory | ||
order vs. observation | Order | ||
Associated Observations | |||
LOINC codes that represent optional associated observation(s) for a clinical observation or laboratory test. A LOINC term may represent a single associated observation or panel containing several associated observations. | |||
History/Usage | |||
first released | |||
last updated | 2.68 | ||
last change type | ADD - added | ||
Related Names | |||
|
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.
Thank you for choosing Find-A-Code, please Sign In to remove ads.